110 related articles for article (PubMed ID: 38110132)
21. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.
Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J
Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235
[TBL] [Abstract][Full Text] [Related]
22. Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments.
Peng H; Huang Z; Li P; Sun Z; Hou X; Li Z; Sang R; Guo Z; Wu S; Cao Y
J Ethnopharmacol; 2024 Mar; 321():117518. PubMed ID: 38042385
[TBL] [Abstract][Full Text] [Related]
23. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
[TBL] [Abstract][Full Text] [Related]
24. Tong-Xie-Yao-Fang promotes dendritic cells maturation and retards tumor growth in colorectal cancer mice with chronic restraint stress.
Jiang Y; Hu Y; Yang Y; Yan R; Zheng L; Fu X; Xiao C; You F
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117069. PubMed ID: 37619860
[TBL] [Abstract][Full Text] [Related]
25. Thermosensitive hydrogels for local delivery of 5-fluorouracil as neoadjuvant or adjuvant therapy in colorectal cancer.
Al Sabbagh C; Seguin J; Agapova E; Kramerich D; Boudy V; Mignet N
Eur J Pharm Biopharm; 2020 Dec; 157():154-164. PubMed ID: 33222768
[TBL] [Abstract][Full Text] [Related]
26. Antitumor effects of the silencing of programmed cell death ligand 1 in colorectal cancer via immunoregulation.
Chen Y; Huang Y; Lu X; Wang G; Chi P
Oncol Rep; 2018 Dec; 40(6):3370-3380. PubMed ID: 30272332
[TBL] [Abstract][Full Text] [Related]
27. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J
Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566
[TBL] [Abstract][Full Text] [Related]
28. Identification of the anti-tumor activity and mechanisms of nuciferine through a network pharmacology approach.
Qi Q; Li R; Li HY; Cao YB; Bai M; Fan XJ; Wang SY; Zhang B; Li S
Acta Pharmacol Sin; 2016 Jul; 37(7):963-72. PubMed ID: 27180984
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory ASIC2-mediated calcineurin/NFAT against colorectal cancer by triterpenoids extracted from Rhus chinensis Mill.
Wang G; Wang YZ; Yu Y; Wang JJ
J Ethnopharmacol; 2019 May; 235():255-267. PubMed ID: 30772482
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice.
Stoeltzing O; Liu W; Reinmuth N; Fan F; Parry GC; Parikh AA; McCarty MF; Bucana CD; Mazar AP; Ellis LM
Int J Cancer; 2003 Apr; 104(4):496-503. PubMed ID: 12584749
[TBL] [Abstract][Full Text] [Related]
31. Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.
Wang D; Jiang W; Zhu F; Mao X; Agrawal S
Int J Oncol; 2018 Sep; 53(3):1193-1203. PubMed ID: 29956749
[TBL] [Abstract][Full Text] [Related]
32. Integrated network pharmacology and experimental verification to investigate the mechanisms of YYFZBJS against colorectal cancer
Li J; Zhou F; Shang L; Liu N; Liu Y; Zhang M; Wang S; Yang S
Front Oncol; 2022; 12():961653. PubMed ID: 36457504
[TBL] [Abstract][Full Text] [Related]
33. Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway.
Huang SZ; Liu WY; Huang Y; Shen AL; Liu LY; Peng J
Chin J Integr Med; 2019 Feb; 25(2):116-121. PubMed ID: 29948597
[TBL] [Abstract][Full Text] [Related]
34. Chinese herbal formula, Bing De Ling, enhances antitumor effects and ameliorates weight loss induced by 5-fluorouracil in the mouse CT26 tumor model.
Xu Q; Brabham JG; Zhang S; Munster P; Fields K; Zhao RJ; Yu H
DNA Cell Biol; 2005 Jul; 24(7):470-5. PubMed ID: 16008516
[TBL] [Abstract][Full Text] [Related]
35. Antitumor, Immunomodulatory and Antiangiogenic Efficacy of Medicinal Mushroom Extract Mixtures in Advanced Colorectal Cancer Animal Model.
Jakopovic B; Oršolić N; Kraljević Pavelić S
Molecules; 2020 Oct; 25(21):. PubMed ID: 33126765
[TBL] [Abstract][Full Text] [Related]
36. Integration of novel agents in the treatment of colorectal cancer.
Iqbal S; Lenz HJ
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512
[TBL] [Abstract][Full Text] [Related]
37. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X
Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806
[TBL] [Abstract][Full Text] [Related]
38. TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression.
Nakamura S; Yaguchi T; Kawamura N; Kobayashi A; Sakurai T; Higuchi H; Takaishi H; Hibi T; Kawakami Y
J Immunother; 2014; 37(2):63-72. PubMed ID: 24509168
[TBL] [Abstract][Full Text] [Related]
39. Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model.
Iwai T; Sugimoto M; Harada S; Yorozu K; Kurasawa M; Yamamoto K
Oncol Rep; 2016 Aug; 36(2):626-32. PubMed ID: 27350037
[TBL] [Abstract][Full Text] [Related]
40. Enhanced anti-colorectal cancer effects of carfilzomib combined with CPT-11 via downregulation of nuclear factor-κB in vitro and in vivo.
Tang W; Su G; Li J; Liao J; Chen S; Huang C; Liu F; Chen Q; Ye Y
Int J Oncol; 2014 Sep; 45(3):995-1010. PubMed ID: 24968890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
